ArticleHuman vaccines & immunotherapeutics2015

Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.

Emmanuelle Préaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.